正大企業國際：2020中期報告.pdf

1、INTERIM REPORT 2020 中期報告CHIA TAI ENTERPRISES INTERNATIONAL LIMITED 正 大 企 業 國 際 有 限 公 司Incorporated in Bermuda with limited liability Stock Code:3839於 百 慕 達 註 冊 成 立 之 有 限 公 司 股份代號:383901IN T ERIM REP OR T 2020二 零 二 零 年 中 期 報 告正 大 企 業 國 際 有 限 公 司 CHIA TAI ENTERPRISES INTERNATIONAL LIMITED2Management D

2、iscussion and Analysis 管理層討論及分析6Report on Review of Interim Financial Report中期財務報告之審閱報告8Consolidated Statement of Comprehensive Income綜合全面收益表10Consolidated Statement of Financial Position綜合財務狀況表12Consolidated Statement of Changes in Equity綜合權益變動表14Condensed Consolidated Statement of Cash Flows簡明綜合現金

3、流量表15Notes to Interim Financial Report中期財務報告附註30Other Information其他資料35Corporate Information 公司資料 Contents目 錄02IN T ERIM REP OR T 2020二 零 二 零 年 中 期 報 告正 大 企 業 國 際 有 限 公 司 CHIA TAI ENTERPRISES INTERNATIONAL LIMITEDGROUP RESULTSThe Group has two lines of businesses:biochemical business and industrial

4、business.The biochemical business,which focuses on the manufacture and sale of chlortetracycline(“CTC”)products and is carried on by Group subsidiaries,accounts for all of the Groups consolidated revenue.The industrial business comprises the Groups interest in its joint venture ECI Metro Investment

5、Co.,Ltd.(together with its subsidiaries,“ECI Metro”),and its associate Zhanjiang Deni Vehicle Parts Co.,Ltd.(together with its subsidiaries,“Zhanjiang Deni”).The results of the Groups industrial business are incorporated in the consolidated statement of comprehensive income as share of profits from

6、joint venture and associate.For the six months ended 30 June 2020(“1H20”),the Groups revenue was US$46.83 million,a decrease of 7.1%compared to the first half of 2019(“1H19”)(1H19:US$50.42 million).Gross profit margin declined by 2.4 percentage points to 27.4%(1H19:29.8%).Profit attributable to shar